Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
GDMC logo — GDMC is a next generation design and manufacturing organizat...

GDMC

GDMC is a next generation design and manufacturing organization focused next-gen advanced genetic medicines.

Founded 2021 Singapore Singapore 61 employees Series A Total: $21.00M Biopharma, Biotechnology +2

General Information

Company Name GDMC
Founded Year 2021
Location Singapore Singapore
Employees 61
Industries Biopharma, Biotechnology, Manufacturing +1
Funding Stage Series A
Business Model B2B, B2B2B, D2C
Revenue Model Service Fee, Consulting Fee, Project Based
Social

BounceWatch is an independent company data service, not affiliated with GDMC. To contact GDMC, visit gdmc.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GDMC compare?

A PDF of GDMC and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GDMC soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GDMC

GDMC, short for Genetic Design and Manufacturing Corporation, represents an ambitious stride in the biopharmaceutical industry, founded in 2021. Positioned at the forefront of next-generation advanced genetic medicines, GDMC operates out of Singapore, focusing on partnerships with early-stage companies and innovative investigators to propel pioneering therapeutic modalities, including gene therapies and nucleic acids.

The company stands out with its robust capabilities in process development and manufacturing, aimed at expediting the journey from clinical trials to market availability—a critical edge in the competitive biopharma landscape. Encouraging a dynamic work environment, GDMC underscores its commitment to diversity and equal opportunities in its rapidly growing team.

Recently, GDMC secured a $21.00M Series A investment on 01 January 2024, from notable investors such as WI Harper Group, SEEDS Capital, NSG Ventures, and Celadon Partners, signalling strong investor confidence and fueling its development trajectory.

Business keywords: genetic medicines, gene therapies, nucleic acid therapies, process development, bio manufacturing, therapeutic modalities, clinical trials support, early-stage partnerships, innovation in healthcare, drug development acceleration, facility development, patient-centric innovations, equal opportunity employer

Services & Products

karaoke room rental
themed entertainment experiences
personalized customer service

Target Customers

young adults university students music enthusiasts private event organizers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $21.00M 4
WI Harper Group SEEDS Capital NSG Ventures
WI Harper Group, SEEDS Capital +2
01 Jan 2024

GDMC Alternatives & Competitors

View All Alternatives
GDMC vs
Waisman Biomanufacturing
Waisman Biomanufacturing United States

GMP Contract Manufacturing Organization for Biological Therapies and Vaccines for Human Clinical Tri...

28 employees
Biotechnology, Health Care
Compare GDMC vs Waisman Biomanufacturing
GDMC vs
Aera Therapeutics
Aera Therapeutics United States

Enabling the next generation of transformative genetic medicines

Series B
91 employees
Biotechnology, Pharmaceutical
Compare GDMC vs Aera Therapeutics
GDMC vs
Anjarium Biosciences AG
Anjarium Biosciences AG Switzerland

DNA to Catalyze Your Advanced Therapies

Series A
15 employees
Biotechnology, Pharmaceutical
View all alternatives

FAQ About GDMC

GDMC is a next generation design and manufacturing organization focused next-gen advanced genetic medicines.
GDMC was founded in 2021.
GDMC is headquartered in Singapore.
GDMC operates in Biopharma, Biotechnology, Manufacturing and Pharmaceutical. Its work centres on genetic medicines, gene therapies, nucleic acid therapies and process development. Its customers include young adults, university students and music enthusiasts.
GDMC has a B2B, B2B2B and D2C business model. Its revenue comes from Service Fee, Consulting Fee and Project Based.
GDMC has approximately 61 employees.
GDMC has completed 1 funding round, raising a total of $21.00M. The latest funding stage is Series A.
GDMC offers: karaoke room rental, themed entertainment experiences, personalized customer service.
Top alternatives and competitors to GDMC include Waisman Biomanufacturing, Aera Therapeutics, Anjarium Biosciences AG, Autotelic Bio Inc., Gates Biomanufacturing Facility. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GDMC and Waisman Biomanufacturing are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GDMC, https://bouncewatch.com/company/gdmc, updated 28 January 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout